Glaucoma
📧 Sign up to get email alerts when something new happens for Glaucoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2014-11-21Clinical Trial Update: Effects of Common Topical Glaucoma Therapy on Optic Nerve Head Blood Flow Autoregulation During Increased Arterial Blood Pressure and Artificially Elevated Intraocular Pressure in Healthy Humans [NA]
A clinical trial evaluating a common topical glaucoma therapy's effect on optic nerve head blood flow autoregulation during increased arteri…
-
CLINICAL_TRIALS withdrawal · 2014-11-21Clinical Trial Update: Effect of Rosuvastatin on Endothelial Function in Patients With Diabetes and Glaucoma [Phase 4]
This Phase 4 trial evaluating rosuvastatin's effect on endothelial function in patients with diabetes and glaucoma has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2014-11-21Clinical Trial Update: Neurovascular Coupling in Patients With Open Angle Glaucoma
A clinical trial investigating neurovascular coupling in patients with open-angle glaucoma was terminated.
-
CLINICAL_TRIALS trial_result · 2014-11-19Clinical Trial Update: Efficacy and Safety Assessment of T2345 in Ocular Hypertensive or Glaucomatous Patients [Phase 3]
Phase 3 clinical trial assessing the efficacy and safety of T2345 in patients with glaucoma or ocular hypertension has completed with result…
-
CLINICAL_TRIALS trial_result · 2014-11-19Clinical Trial Update: Evaluation of Objective Perimetry Using Pupillometer
A completed clinical trial evaluating objective perimetry using a pupillometer to measure visual fields in patients with Retinitis Pigmentos…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2014-11-18FDA Approved: BRIMONIDINE TARTRATE — Original Application (Florida Pharmaceutical Products, LLC)
FDA approved Brimonidine tartrate from Florida Pharmaceutical Products, LLC under an Original Application (ANDA), enabling its entry as a ge…
-
CLINICAL_TRIALS trial_result · 2014-10-29Clinical Trial Update: Safety, Efficacy Assessment of Geltim LP® 1 mg/g in Ocular Hypertensive or Glaucomatous Patients. [Phase 4]
Phase 4 study evaluating the safety and efficacy of Geltim LP 1 mg/g in ocular hypertensive or glaucomatous patients. Results have been post…
-
CLINICAL_TRIALS trial_result · 2014-09-29Clinical Trial Update: OCT Agreement and Crossed Precision Study
The document reports a completed OCT-related clinical trial update from Nidek Co. LTD regarding an OCT agreement and a crossed precision stu…
-
FDA approval · 2014-09-25FDA Approved: MITOSOL — Supplemental Application (Mobius Therapeutics LLC)
The FDA approved a supplemental application for MITOSOL (mitomycin C) from Mobius Therapeutics LLC. The approval expands its ophthalmic labe…
-
FDA approval · 2014-09-25FDA Approved: BRIMONIDINE TARTRATE — Supplemental Application (Sandoz Inc)
The FDA approved a supplemental application for Brimonidine Tartrate filed by Sandoz Inc. The document does not specify the exact scope of t…
-
CLINICAL_TRIALS trial_result · 2014-09-25Clinical Trial Update: Tolerability of Bimatoprost 0.01% vs Latanoprost Eye Drops
Completed clinical trial comparing tolerability of bimatoprost 0.01% eye drops versus latanoprost eye drops in glaucoma; results were posted…
-
CLINICAL_TRIALS trial_result · 2014-09-23Clinical Trial Update: Effect of Nitrous Oxide (N2O) on Intraocular Pressure in Healthy Volunteers [Phase 4]
Phase 4 clinical trial update evaluating the effect of nitrous oxide on intraocular pressure in healthy volunteers; results have been posted…
-
FDA approval · 2014-09-19FDA Approved: LUMIGAN — Supplemental Application (Allergan, Inc.)
FDA approved Allergan's supplemental application for LUMIGAN (bimatoprost).
-
FDA approval · 2014-09-03FDA Approved: DORZOLAMIDE HYDROCHLORIDE TIMOLOL MALETAE — Original Application (Indoco Remedies Limited)
FDA approved Indoco Remedies Limited's generic dorzolamide hydrochloride-timolol maleate ophthalmic solution for lowering intraocular pressu…
-
CLINICAL_TRIALS research · 2014-08-26Clinical Trial Update: An Open Label Study Assessing the 24-hour Intraocular Pressure Pattern in PAC and PACG Patients, Before and After Laser Peripheral Iridotomy [NA]
An open-label study completed to evaluate 24-hour intraocular pressure patterns in patients with primary angle-closure glaucoma and primary …
-
CLINICAL_TRIALS trial_result · 2014-08-18Clinical Trial Update: Effects of a Single OMT on Intraocular Pressure (IOP) in Ocular Hypertenive or Glaucoma Suspect Subjects [NA]
A completed clinical trial evaluating the effect of a single OMT session on intraocular pressure in subjects with ocular hypertension or gla…
-
CLINICAL_TRIALS trial_result · 2014-08-07Clinical Trial Update: PRM-151 in the Prevention of Scarring Following Trabeculectomy [Phase 2]
Phase 2 trial evaluating PRM-151 to prevent scarring after trabeculectomy in glaucoma; study completed with results posted in 2014.
-
CLINICAL_TRIALS research · 2014-08-06Clinical Trial Update: Combined Ex-PRESS Implantation Alone or With Phacoemulsification for Glaucoma Associated With Cataract
A clinical trial compares Ex-PRESS glaucoma implant alone versus with phacoemulsification for glaucoma associated with cataract; the trial s…
-
CLINICAL_TRIALS trial_result · 2014-08-05Clinical Trial Update: Spectralis OCT Repeatability and Reproducibility Study [NA]
This clinical trial update evaluates the repeatability and reproducibility of Spectralis OCT imaging in glaucoma.
-
CLINICAL_TRIALS trial_result · 2014-07-24Clinical Trial Update: Short-term Outcomes of Iridoplasty for Persistent Angle Closure Despite Patent Iridotomies [NA]
This clinical trial update reports short-term outcomes of iridoplasty for persistent angle closure in eyes with patent iridotomies.
-
CLINICAL_TRIALS trial_result · 2014-07-21Clinical Trial Update: Pharmacokinetic and Safety Study of Travoprost 0.004% in Pediatric Glaucoma Patients [Phase 1]
Phase 1 pharmacokinetic and safety study of Travoprost 0.004% ophthalmic solution in pediatric glaucoma patients has completed and results w…
-
CLINICAL_TRIALS trial_result · 2014-07-11Clinical Trial Update: Patient Preference Study [Phase 3]
This is a Phase 3 patient-preference trial sponsored by Alcon Research. It focuses on glaucoma and ocular hypertension; the study status is …
-
CLINICAL_TRIALS trial_result · 2014-07-03Clinical Trial Update: Pilot Study on the Use of Artificial Tears to Treat Dry Eye in Glaucoma Patients [Phase 4]
Phase 4 pilot trial evaluated artificial tears for treating dry eye symptoms in patients with glaucoma; results were posted in 2014.
-
CLINICAL_TRIALS trial_result · 2014-07-01Clinical Trial Update: Efficacy and Tolerability of AZARGA® as Replacement Therapy in Patients on COMBIGAN® Therapy in Canada [Phase 4]
Phase 4 Canadian study evaluating the efficacy and tolerability of AZARGA as a replacement therapy for patients on COMBIGAN, with results po…
-
CLINICAL_TRIALS trial_result · 2014-06-19Clinical Trial Update: 24-hour IOP-lowering Effect of 0.01% Bimatoprost [Phase 4]
A Phase 4 clinical trial reports that 0.01% bimatoprost lowers intraocular pressure over a 24-hour period. The study results were posted in …